KMTS - Company ID 0001877184
The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $24.55M | $22.57M | $19.37M | $15.09M | $14.71M | $12.78M |
| Cost of revenue | $11.65M | $11.14M | $10.52M | $8.54M | $8.88M | $8.58M |
| Gross profit | $12.91M | $11.42M | $8.85M | $6.55M | $5.83M | $4.20M |
| R&D | $4.97M | $4.88M | $4.00M | $3.35M | $3.51M | $3.40M |
KESTRA MEDICAL TECHNOLOGIES, LTD. reported annual revenue of $59.81M for fiscal year 2025. That is up 115.1% from $27.81M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $42.70M | $38.30M | $33.73M | $23.80M | $21.45M | $19.23M |
| Operating income | -$34.77M | -$31.75M | -$28.88M | -$20.60M | -$19.13M | -$18.43M |
| Income tax | $35.00K | $34.00K | $33.00K | $18.00K | $8.00K | $7.00K |
| Net income | -$34.17M | -$32.78M | -$25.83M | -$21.51M | -$20.37M | -$19.88M |
| EPS (diluted) | -$0.61 | -$0.64 | -$0.50 | -$1.25 | -$1.19 | -$1.12 |